Revolutionizing liver transplants in pigs with magnetic anastomosis technology

In a land­mark mo­ment for ge­net­ic med­i­cine and sick­le cell dis­ease pa­tients, the FDA on Fri­day ap­proved not just one but two gene ther­a­pies for

Mod­er­na’s chief com­mer­cial of­fi­cer Arpa Garay has left her role as the com­pa­ny moves to “in­crease ex­ec­u­tive fo­cus” on sales, it an­nounced Tues­day morn­ing. The